Verseon presents oral anti-coagulant treatment at Honolulu stroke conference
Clinical-stage pharmaceutical company Verseon said it presented its oral anti-coagulant treatment last week at the International Stroke Conference in Honolulu.
The company said it presented pre-clinical efficacy...
11 February 2019 09:19